A Pill to Fill the Gap in Cholesterol Care The FDA has approved Merck's Lipfendra, a pill that significantly reduces cholesterol levels.
This breakthrough in cardiovascular disease treatment is being hailed as a major advancement, but it also raises complex medical and economic questions.
A Long Overdue Solution For years, patients with high cholesterol have been stuck between statins, which often fall short in reducing LDL (bad) cholesterol levels, and expensive injectable drugs targeting PCSK9.